These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28486002)

  • 1. Comparison of Fentanyl Oral and Nasal Formulations #331.
    Malotte KL; Groninger H
    J Palliat Med; 2017 Jul; 20(7):784-786. PubMed ID: 28486002
    [No Abstract]   [Full Text] [Related]  

  • 2. Fentanyl nasal spray (Lazanda) for pain.
    Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):99-100. PubMed ID: 22173454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fentanyl intranasal. Breakthrough cancer pain: unsafe packaging.
    Prescrire Int; 2010 Nov; 19(110):251. PubMed ID: 21284356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fentanyl nasal spray for the treatment of cancer pain.
    Mystakidou K; Panagiotou I; Gouliamos A
    Expert Opin Pharmacother; 2011 Jul; 12(10):1653-9. PubMed ID: 21609189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal fentanyl for acute severe pain episodes control in a dog.
    Micieli F; Santangelo B; Napoleone G; Di Dona F; Mennonna G; Vesce G
    Vet Anaesth Analg; 2017 Nov; 44(6):1400-1401. PubMed ID: 29174209
    [No Abstract]   [Full Text] [Related]  

  • 6. Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain.
    Zeppetella G
    Palliat Med; 2000 Jan; 14(1):57-8. PubMed ID: 10717724
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral transmucosal fentanyl citrate--OTFC (ACTIQ) #103.
    Gordon D; Schroeder M
    J Palliat Med; 2008 May; 11(4):633-4. PubMed ID: 18454617
    [No Abstract]   [Full Text] [Related]  

  • 8. Fentanyl for breakthrough pain: a systematic review.
    Davis MP
    Expert Rev Neurother; 2011 Aug; 11(8):1197-216. PubMed ID: 21797660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fentanyl pectin nasal spray for breakthrough cancer pain.
    Torres LM; Trinidad JM; Calderón E; Benitez D; Perelman M
    Int J Palliat Nurs; 2015 Mar; 21(3):114-6. PubMed ID: 25815759
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of oral formulations of fentanyl for breakthrough cancer pain.
    Handsaker S; Dempsey L; Fabby C
    Int J Palliat Nurs; 2015 Apr; 21(4):168, 170-2. PubMed ID: 25901588
    [No Abstract]   [Full Text] [Related]  

  • 11. Breakthrough pain: progress in management.
    Lossignol DA; Dumitrescu C
    Curr Opin Oncol; 2010 Jul; 22(4):302-6. PubMed ID: 20489619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistency of efficacy, patient acceptability, and nasal tolerability of fentanyl pectin nasal spray compared with immediate-release morphine sulfate in breakthrough cancer pain.
    Davies A; Sitte T; Elsner F; Reale C; Espinosa J; Brooks D; Fallon M
    J Pain Symptom Manage; 2011 Feb; 41(2):358-66. PubMed ID: 21334555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there cost benefits to fentanyl for breakthrough pain?
    Davis MP
    J Pain Symptom Manage; 2012 Sep; 44(3):e1-2. PubMed ID: 22939453
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient satisfaction with intranasal fentanyl for breakthrough pain.
    Veldhorst-Janssen NM; Fiddelers AA; Zandstra H; Kessels AG; Zandstra H; Marcus MA; Neef C; van der Kuy PH
    J Palliat Med; 2012 Jun; 15(6):631-2. PubMed ID: 22656053
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and Safety of Oral or Nasal Fentanyl for Treatment of Breakthrough Pain in Cancer Patients: A Systematic Review.
    Rogríguez D; Urrutia G; Escobar Y; Moya J; Murillo M
    J Pain Palliat Care Pharmacother; 2015 Sep; 29(3):228-46. PubMed ID: 26458018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Understanding Oral and Nasal Mucosal Absorption of Fentanyl, and Rectal Absorption of Buprenorphine].
    Shimoyama N; Shimoyama M; Kubota Y; Kato Y
    Masui; 2015 Nov; 64(11):1160-5. PubMed ID: 26689067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral transmucosal fentanyl and sufentanil for incident pain.
    Gardner-Nix J
    J Pain Symptom Manage; 2001 Aug; 22(2):627-30. PubMed ID: 11503630
    [No Abstract]   [Full Text] [Related]  

  • 18. Intranasal fentanyl for pain management in children: a systematic review of the literature.
    Mudd S
    J Pediatr Health Care; 2011; 25(5):316-22. PubMed ID: 21867860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New formulations of fentanyl for acute pain management.
    Paech MJ; Bloor M; Schug SA
    Drugs Today (Barc); 2012 Feb; 48(2):119-32. PubMed ID: 22384452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patient-controlled analgesia with iontophoretic fentanyl].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2008 May; 31(5):189-91. PubMed ID: 18552078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.